The position is primarily responsible for supporting senior management in licensing and/or M&A activities. Primary responsibilities fall into two major roles - search and evaluation support and transaction support. Search and evaluation support includes: Screening products, companies and therapeutic areas Product/market financial modeling Conducting primary and secondary market research Coordinating due diligence of transaction opportunities Transaction support includes: Negotiation support Contract review.
BASIC QUALIFICATIONS:
Minimum Education & Experience Requirements:
Knowledge/Skills Needed: Strong analytical, communication, project management and project leadership skills, as well as the ability to execute plans/projects on fast-moving timelines, are essential.
Quantitative Skills: Ability to perform complex financial analyses such as product forecasting, pro-forma product P&L modeling (including sensitivity analyses), probability adjusted net present value, internal rate of return, etc.
Reasoning Ability:
Research Experience: Experience with qualitative and quantitative market research techniques is strongly preferred.
Business Acumen: A broad business understanding (particularly of the pharmaceutical/biotech industry) and the ability to coordinate cross-functionally is essential.
PREFERRED QUALIFICATIONS:
Communication Skills: The ability to make professional and credible first impressions with internal and external customers and write/present clear, succinct and convincing presentations at varying levels of detail depending on the project scope and audience is important to this position.
Other Skills and Abilities:
Personal Attributes Needed:
#LI-TS1
Why join Team Alkermes?
Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A fully-integrated, global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we are committed to pursuing great science, driven by deep compassion to make a real impact in the lives of patients. Alkermes has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for various neurological disorders, including narcolepsy.
Beyond our important mission of developing medicines to address unmet patient needs, we actively seek to foster a culture of diversity, inclusion and belonging throughout our business. We strive to ensure that all voices are respected and valued, recognizing that our diversity of thought, background and perspective makes us stronger. We are proud to have been recognized as an employer of choice by many national organizations, including being certified as a Great Place to Work in the U.S. in 2024, honored as a Healthiest Employer in both Ohio and Massachusetts in 2023, a Best Place for Working Parents in 2023, and to have received the Bell Seal at the Platinum level for Workplace Mental Health by Mental Health America for three consecutive years (2021-2023).
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.
Read Full Description